Positive neonatal direct antiglobulin test and free circulating panagglutinin due to high‐titer immunoglobulin G1 anti‐In b without in vivo hemolysis
Transfusion · 2026-11 · 66 (11) · 2490-2495
DOI: 10.1111/trf.70384 ↗Kurz gefasst
Fallbericht in der Zeitschrift Transfusion, online erschienen am 31.08.2026. Verfasst von Salim Oulghazi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunohematology, German Red Cross Blood Donor Service Baden-Württemberg-Hesse, Frankfurt, Germany. Hauptthemen laut MEDLINE: Coombs Test, Hemolysis, Isoantibodies, Immunoglobulin G. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Background
The cluster of differentiation 44 glycoprotein carries the Indian blood group system, including the antithetical antigens In a and In b . The In b antigen is highly prevalent, with more than 99.9% of Caucasians being In b ‐positive, whereas In b ‐negative individuals are found almost exclusively in South Asian populations (~0.02%). Anti‐In b can cause hemolytic transfusion reactions, but little data are available on hemolytic disease of the fetus and newborn (HDFN), suggesting minimal placental transfer, with only one reported case of a positive neonatal direct antiglobulin test (DAT). Case Report A woman of Indian origin developed an anti‐In b alloantibody with a titer of 64 during her first pregnancy. This was detected only at delivery, with no evidence of transplacental transfer of antibodies or HDFN. The anti‐In b titer increased after delivery, reaching a peak of 1024, and remained stable throughout the second pregnancy. At birth, the second neonate showed a strongly positive DAT, with anti‐In b detectable in both the plasma and eluate, confirming transplacental transfer and red blood cell binding. Testing of maternal plasma showed immunoglobulin G1 predominance over immunoglobulin G3 and moderate‐to‐high hemolytic potential in the monocyte monolayer assay and antibody‐dependent cellular cytotoxicity (ADCC) test, with a monocyte index of 7.7–10% and ADCC of ~40%. Despite these findings, the neonate exhibited no signs of hemolysis.
Conclusion
This case demonstrates that high‐titer, functionally active maternal anti‐In b antibodies can coexist with neonatal anti‐In b reactivity without causing hemolysis. The marked discrepancy between serological, functional, and clinical findings underscores the limited predictive value of current assays in rare blood group incompatibilities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunohematology, German Red Cross Blood Donor Service Baden-Württemberg-Hesse, Frankfurt, Germany.
- Department of Immunohematology, Interregional Blood Transfusion SRC Ltd., Bern, Switzerland.
- Faculty of Medicine, Institute for Transfusion Medicine and Immunohematology, Goethe University, Frankfurt, Germany.
ORCID-Profile: Salim Oulghazi, Sofia Lejon Crottet, Halvard Bonig, Susanne Braeuninger
Zitieren
APA
Oulghazi, S., Albers, S., Crottet, S. L., Bonig, H., & Braeuninger, S. (2026). Positive neonatal direct antiglobulin test and free circulating panagglutinin due to high‐titer immunoglobulin G1 anti‐In b without in vivo hemolysis. Transfusion, 66(11), 2490-2495. https://doi.org/10.1111/trf.70384
Vancouver
Oulghazi S, Albers S, Crottet SL, Bonig H, Braeuninger S. Positive neonatal direct antiglobulin test and free circulating panagglutinin due to high‐titer immunoglobulin G1 anti‐In b without in vivo hemolysis. Transfusion. 2026;66(11):2490-2495. doi:10.1111/trf.70384
BibTeX
@article{Oulghazi2026,
author = {Oulghazi, Salim and Albers, Siebo and Crottet, Sofia Lejon and Bonig, Halvard and Braeuninger, Susanne},
title = {Positive neonatal direct antiglobulin test and free circulating panagglutinin due to high‐titer immunoglobulin G1 anti‐In b without in vivo hemolysis},
journal = {Transfusion},
year = {2026},
volume = {66},
number = {11},
pages = {2490--2495},
doi = {10.1111/trf.70384}
}
EUVIMED